Orchestra BioMed
OBIO
OBIO
54 hedge funds and large institutions have $77M invested in Orchestra BioMed in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $97.8M → $77M (-$20.8M)
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$207K | |
| 2 | +$196K | |
| 3 | +$116K | |
| 4 |
Goldman Sachs
New York
|
+$108K |
| 5 |
State Street
Boston,
Massachusetts
|
+$97.2K |
Top Sellers
| 1 | -$137K | |
| 2 | -$98K | |
| 3 | -$63K | |
| 4 |
Morgan Stanley
New York
|
-$42.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42.1K |